Risperdal is Causing Gynecomastia in Young Boys
If you or a loved one have experienced side effects or complications after using Risperdal you may be eligible to file a claim against Johnson & Johnson. Houston attorney Mark Lanier and his firm are investigating claims that Johnson & Johnson and its Janssen unit hid serious risks when marketing the antipsychotic drug Risperdal (risperidone). Just simply call The Lanier Law Firm or fill out the form to see if you are eligible for a potential Risperdal lawsuit.
Risperdal is an atypical anti-psychotic medication approved to treat symptoms of schizophrenia, bipolar disorder, and autism. Unfortunately, thousands of doctors have prescribed Risperdal for unapproved uses, with serious consequences. The use of Risperdal has been linked to a condition called gynecomastia, or the enlargement of male breast tissue. This condition has been seen in young boys who have used Risperdal.
More than 420 lawsuits have been filed against Johnson & Johnson alleging serious personal injuries, and the U.S. Food & Drug Administration has issued several warnings related to the drug. Additionally, Johnson & Johnson has paid billions of dollars to resolve federal and state government allegations that the company illegally marketed several drugs, including Risperdal.
Do not delay! Your Risperdal lawsuit may have time sensitive criteria that may prevent you from filing a case. Contact us today to see if you are eligible for a Risperdal lawsuit.
Risperdal has been linked to many severe side effects, including:
Mark Lanier has earned widespread recognition as one of the top trial lawyers in the United States. His work for clients across the country is supported by firm offices in Houston, New York and Los Angeles. His peers and the media consistently recognize Mark Lanier among the country’s leading legal minds. In its coverage of Mark Lanier’s stunning verdict in the nation’s first Vioxx trial Ernst v. Merck, The New York Times described him as “one of the top civil trial lawyers in America…” Under his leadership, U.S. News and World Report has named The Lanier Law Firm to its list of Best Law Firms over the last three years. Further, U.S. News and World Report’s Best Lawyers has named Mark Lanier to its Best Lawyers in America list for nine consecutive years and most recently as the 2013 Top Class Action Attorney in America. The National Law Journal has twice named him one of the nation’s Top 10 Trial Attorneys, as well as naming Mark as one of the 100 Most Influential Lawyers in America. In 2010, The National Law Journal named Mark as one of the most Influential Attorneys of the Decade. He has earned similar honors from other publications, including being named to The Trial Lawyer Magazine’s America’s 100 Most Influential Trial Lawyers of 2011.learn more
Founded in 1990 by Mark Lanier, The Lanier Law Firm is committed to addressing client concerns with effective and often untraditional solutions. Our clients, as diverse as they are, all have one common trait: they need serious and sound legal representation, whether they are physically injured or in the midst of a business dispute. The Lanier Law Firm is a pioneer in its involvement in numerous pharmaceutical liability litigations, with an extremely successful track record. The Pharmaceutical Liability Practice Group at The Lanier Law Firm has decades of experience representing clients who have been injured as a result of the negligence of others. The firm garnered national attention during its VIOXX litigation, most notably winning a substantial verdict against Merck & Co. in the very first VIOXX lawsuit to go to trial as well as securing two additional very significant plaintiff verdicts.
Several of the firm’s attorneys serve or have served as counsel to large national insurance companies, giving them a unique perspective on how to build the strongest case on behalf of their clients. The pharmaceutical attorneys at The Lanier Law Firm offer a unique blend of compassion, empathy and zealousness, and are committed to achieving nothing less for their clients than the fullest remedies available under law.learn more
Mark’s courtroom work has resulted in feature articles in The Wall Street Journal, The New York Times, The American Lawyer, The National Law Journal, Los Angeles Times, The Boston Globe, Bloomberg, New York Lawyer, Texas Lawyer, and Houston Chronicle among others. He also is a frequent guest on news shows such as CNBC’s “Squawk Box” and Fox News’ “Your World with Neil Cavuto” and Fox business News’ “Money – With Melissa Francis”. He also is a regular Co-Host and contributor to Fox Business News’ highly rated “Varney and Company” with Stuart Varney.